Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus.
JAMA dermatology(2023)
摘要
This case series examines the efficacy of anifrolumab as a therapeutic option for patients with lupus erythematosus.
更多查看译文
关键词
anifrolumab,clinical response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要